Joseph Shulman's Stock Transactions in Rhythm Pharmaceuticals Inc

Joseph Shulman, an officer at Rhythm Pharmaceuticals Inc, has filed a Form 144 notice indicating the intent to sell 2,815 shares of common stock acquired through the exercise of stock options. The shares were acquired on October 28, 2025, and are planned to be sold on the same date. The aggregate market value of these shares is approximately $314,013.25. Additionally, Shulman has engaged in several significant stock transactions over the past three months, including sales on October 16, 2025 ($1,617,336.87), September 2, 2025 ($1,767,005.62), August 21, 2025 ($419,090.86), and August 11, 2025 ($358,891.47). These transactions were executed under a 10b5-1 trading plan, which allows company insiders to sell shares at predetermined times to avoid accusations of insider trading.